Publikasi

Thermo and Michael J. Fox Foundation Collaborate to Adv...

PPMI creates a large-scale proteomics resource designed to help researchers stud...

St. Luke’s Unveils $252 Million Heart Hospital at Ander...

St. Luke’s University Health Network is preparing to open a new heart hospital a...

HMC Architects Expands Healthcare Practice

HMC Architects is expanding its healthcare practice into the Pacific Northwest w...

Beehive Acoustic Panels by Momentum

Momentum’s Beehive acoustic wall panel is designed to provide sound absorption w...

The Coming Shift from Biomarkers to Biological Trajecto...

The next era of medicine will not be defined by earlier detection alone, but by ...

Producing Recombinant Antibodies for In Vivo Research

Antibody reagent variability is a leading but frequently underappreciated source...

Long-Term Memory Loss Secrets Revealed with Artificial ...

A study involving artificial hibernation in mice has shown how memories survive ...

Financial Value of AI Agents in Drug Development

Net present value modeling based on actual use and benchmark data was applied to...

Advancing Microbial-Derived Biologics from Scale-Up to ...

In this GEN webinar, our expert speaker, Sam Zhang, PhD, will discuss emerging t...

New Technology Could Expand the Supply of Donor Livers

A new transplant technology being used in Montreal could help doctors make more ...

In Pursuit of Precision: New Lab Tech

Advances in lab technology are helping endocrinology researchers improve accurac...

A-level results day: dental school acceptances hit all-...

Around 12,550 candidates have been accepted onto dentistry and medicine courses ...

Form 4B: why orthodontists are transitioning to in-hous...

A conversation with Jonathan Williamson, digital workflow specialist, on the adv...

How generative AI is exacerbating dental negligence claims

Damian Whitlam explores how generative AI is making it easier for patients to pu...

Akeso secures China NMPA authorisation for ivonescimab ...

The decision marks the third NMPA-approved indication for an ivonescimab-contain...

Remepy secures $36m funding for hybrid drug pipeline ex...

The proceeds will also be used to fund Remepy’s lead product Hybridopa’s global ...